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We describe three novel mutations together 
with two recurrent point mutations in the Norrie 
disease gene of five unrelated patients with Norrie 
syndrome. The two recurrent sequence alterations 
were identified as de novo mutations in the cases 
studied.
Norrie disease is a rare X-linked inherited neu- 
rodevelopmental disorder characterized by congen­
ital blindness, occasionally accompanied by pro­
gressive sensorineural deafness and different degrees 
of mental retardation (for review, see Warburg et 
al,, 1966). Since the isolation and characterization 
of the disease gene (Berger et a l.} 1992a; Chen et 
al., 1992), several different sequence variations, 
mainly missense and nonsense point mutations, 
have been identified in patients with Norrie disease
(Berger et al., 1992b; Meindl et al., 1992; Fuentes 
et al., 1993; Wong et al., 1993; Zhu and Maume­
nee, 1993; Fuchs et atM 1994).
We analysed the genomic DNA of five patients 
by polymerase chain reaction (PCR) amplification 
of the three exons and adjacent intronic sequences 
of the Norrie disease gene followed by single-strand 
conformation polymorphism (SSCP) analysis and 
direct sequencing of PCR products (for experimen­
tal procedures and oligonucleotide PCR primers
see Berger et al., 1992b).
Patient 1 is a nine-year-old member of a three- 
generation family with Norrie disease. In addition 
to the typical ophthalmological features, affected 
males in the family exhibit both mental distur­
bances and hearing impairment. Molecular analy­
sis revealed a G-to-A substitution of the first nu­
cleotide in intron 1 (pos. 209+ 1G—>A according 
to the sequence given in Berger et al., 1992a) of 
the Norrie disease gene. This sequence alteration 
destroys the highly conserved splice donor site 
(AGgt) of exon I/intron 1. The G-to-A transition 
eliminates an Eco81I site present at this position in 
the wild-type sequence (Fig. 1A). Using Eco81I- 
digestion, family analysis was carried out (results 
not shown) ♦ A cosegregation of the mutation and 
the Norrie phenotype was found.
As the first exon of the Norrie disease gene is 
not translated (Meindl et a l., 1992) the open read­
ing frame, which starts in exon 2, should not be 
altered by the mutation found. However, incorrect 
splicing can lead to changes in important sequence 
information for transcript stability or translational 
efficiency, or both. Indeed, it has been shown for 
several different genes, e.g., the human ferritin
gene (Aziz and Munro, 1987) that 5 '-untranslated 
RNA regions may have translational control func­
tion.
Patient 2 is a two-year-old boy with bilateral 
leukocoria and hypoplastic iris, as well as posterior 
synechiae and microcornea in the left eye. Ultra­
sound and computer tomography scan showed that 
both eye chambers were filled up with material. The 
patient had no signs of deafness or psychomotor 
retardation. The family history was negative. DNA 
analysis revealed a G-to-C transversion of the first
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TABLE l. Novel Mutations Detected in the Norrie Disease Gene of Patients With Norrie Disease
Exon______ Mutation______ Nucleotide change______ Amino acid change______ Restriction site
I Splice site 209+1G—»A ? —Eco81I
II Splice site 590 + lG-»C ? +DdeI
III C126X TGT-»TGA Cys-^ter -M ae  III
nucleotide in intron 2 (pos, 590 + 1G—>C). This
substitution creates a new Ddel restriction site at 
this position and can therefore be detected by Ddel 
digestion analysis. By this means, we showed that 
the patient’s mother is heterozygous for this se­
quence alteration (Fig. IB). The G-to-C substitu­
tion destroys the consensus splice donor site (AGgt) 
of exon II/intron 2. Because 9 bp downstream in the 
intron a sequence motif exists that represents a
potential splice donor site (pos 590 + 9: aggt), it is 
possible that this cryptic site is used for splicing. If 
this was the case, the resulting transcript would 
contain an 11-bp insertion causing a shift in the 
open reading frame from codon 38 onward and a 
premature termination of translation after incorpo­
ration of 49 amino acids unrelated to the Norrie 
protein. Hence, as a consequence of this splice site 
mutation, the Norrie protein would lack a major 
part of its genuine amino acid sequence. It is in­
teresting to note that a mutation (590 + 5G-~*C)
affecting the fifth nucleotide of the same splice site 
has already been reported (Berger et aL, 1992b; 
unpublished observation). In spite of the difference 
in the nucleotide exchange, the biological conse­
quence of this latter mutation should be similar to 
that discussed for patient 2.
Patient 3 is a one-year-old boy. His parents 
noted that there was no fixation of objects with 
both eyes when he was 2.5 months of age. The 
only reaction to direct illumination was closure of 
the lids in bright light. In the right eye he pre­
sented with leukocoria, corneal edema, flat ante­
rior chamber, iris atrophy with posterior syn- 
echiae, anterior traction on ciliary processes, 
medium diffuse lens opacities, and dense opacities 
in the vitreous with no visibility of the retina. The 
results of the examination of the left eye exhibited 
a milder stage of the same malformation. Clear 
cornea and lens, normal anterior chamber, and 
only mild traction on ciliary processes were seen. 
There was a dense central vitreous opacity poste­
rior to the lens, and the retina showed a severe 
traction to the temporal side with a retinal fold 
from the optic disk to the upper temporal periph­
ery. Ultrasonography revealed a temporal mass on 
the right eye comparable to the retinal fold in the 
left eye.
In the patient’s DNA, a TG T-TG A  substitu­
tion in codon 126 produced a stop codon 
(C126X), The resulting protein would lack the last 
8 amino acids of the wild-type Norrie protein, in­
cluding three conserved cysteine residues involved 
in the formation of the “cystine knot motif,” a 
structural feature thought to represent a function­
ally important domain by adopting a three-dimen- 
sional structure similar to that of transforming
growth factor-P (TGF-(3) [Meindl et a l., 1992; 
Meitinger et a l ,  1993). The expected gross
changes should lead to instability of the mutant 
protein. The T-to-A substitution destroys a Maelll 
restriction site present at this position in the wild- 
type sequence. Maelll restriction analysis revealed 
that the patient’s mother and maternal grand­
mother carried the same mutation (Fig. 1C),
The mother of the patient has had low vision on 
both eyes since birth. She underwent retinal sur­
gery on the right eye before age one. Visual acuity 
in the right eye was 20/60 at age 31, O n the same 
eye, severe temporal dragging of the retina, includ­
ing the macula, has been detected. Because of lens 
opacity, the fundus was not visible in the phthitic 
left eye. The maternal grandmother had lost one 
eye attributable to unknown cause. The other eye 
was said to be normal, as was the vision in all other 
family members. However, detailed clinical data 
are not available. The eye condition of the pa­
tient’s mother is puzzling, The overall clinical pic­
ture is highly suggestive of a heterozygote manifes­
tation. In general, carriers of Norrie disease are 
asymptomatic. Nonetheless, a manifesting carrier 
with severely impaired vision at the age of two 
years and heterozygous for the C69S-mutation has 
recently been reported (Chen et a l ,  1993). The 
most plausible explanation for the clinical mani­
festation in heterozygotes is skewed X- inactivation 
(in the retina). However, in the mother’s blood 
peripheral leukocytes, there was only a slight shift 
in the pattern of X-inactivation, as was the case for 
the other manifesting carrier described by Chen et
al. (1993).
Patient 4 is a 12-year-old boy with pseudoglioma 
of both retinas compatible with Norrie disease and 
a missense mutation (C-to-G) in codon 74 (R74C) 
that has previously been reported in two other pa-
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tients (Berger et al., 1992; Meindl, personal com­
munication). This mutation is located near the 
“cystine knot motif” and may well interfere with 
its formation by introducing an additional cysteine 
residue. The C-to-G substitution destroys a Mtfelll 
restriction site and was identified in the patient’s 
mother but not in his maternal grandmother or in 
other family members (Fig. ID). Segregation anal­
ysis using a CA-repeat polymorphism at the MAO 
A locus showed that the patient inherited his 
mother’s paternal allele (not shown) suggesting 
that the mutation occurred de novo during sper­
matogenesis in the maternal grandfather. As three 
independent cases of R74C mutation have already 
been identified, this change may represent a mu- 
tation hot spot in the Norrie gene.
Patient 5 is a 19-year-old man whose clinical 
examination revealed phthisis bulbi, cataract, and 
amaurosis in both eyes. Additionally, the patient 
has bilateral sensorineural deafness. His intelli­
gence is normal. No family history of comparable 
symptoms is known. Analysis of the Norrie gene 
revealed a T-to-C transition of the first nucleotide 
in codon 110 of exon III, predicting the substitu­
tion of cysteine by arginine (C110R). This se­
quence alteration has been reported previously in 
one other patient (Zhu and Maumenee, 1993).
The sequence change found creates a new Hgal 
restriction site at this position and can therefore be 
easily detected. Both direct sequencing (not 
shown) and Hgal restriction analysis (Fig. IE) con­
firmed that the mother of the patient did not carry 
the T-to-C transition, suggesting that this se­
quence alteration represented a de novo mutation 
in the Norrie disease gene of the patient studied. 
The replacement of cysteine-110 should consider­
ably alter the structure (and function) of the Nor­
rie protein. In the same codon, a nonsense point 
mutation (C110X) has already been described in a 
patient with Norrie disease (Berger et al., 1992b).
The three novel gene mutations that we have 
identified in patients with Norrie disease represent 
further examples of sequence aberrations that alter 
the structural and/or functional property of the 
Norrie protein and are therefore considered the 
primary genetic cause of the disease in the respec­
tive families. None of the mutations identified in 
this study was detected in 60 unrelated control X 
chromosomes (data not shown).
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